Improving hypertension management through pharmacist prescribing; The rural alberta clinical trial in optimizing hypertension (Rural RxACTION): Trial design and methods

Implementation Science

Volumn 6, Issue 1, 2011, Pages

  Charrois, Theresa L ^a   McAlister, Finlay A ^b,c   Cooney, Dale ^d   Lewanczuk, Richard ^b   Kolber, Michael R ^b   Campbell, Norman R C ^e   Rosenthal, Meagen ^c   Houle, Sherilyn K D ^c   Tsuyuki, Ross T ^b,c  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Alberta College of Pharmacists   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CANADA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MANAGEMENT; FEMALE; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; MALE; MULTICENTER STUDY; NONPARAMETRIC TEST; PHARMACIST; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK FACTOR; RURAL POPULATION; TREATMENT OUTCOME;

ALBERTA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERTENSION; MALE; PHARMACISTS; QUALITY OF HEALTH CARE; REGRESSION ANALYSIS; RISK FACTORS; RURAL POPULATION; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 80051532190     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/1748-5908-6-94     Document Type: Article

References (30)

1. Statistics Canada Canadian health measures survey: Cycle 1 data tables 2007-2009. Statistics Canada., http://www.statcan.gc.ca/pub/82-623-x/82-623-x2010001-eng.pdf
2. National Center for Health Statistics. Health, United States, 2009 With Special Feature on Medical Technology. National Center for Health Statistics. Health, United States, 2009., http://www.cdc.gov/nchs/data/hus/hus09.pdf#highlights
3. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment and control of hypertension, 1988-2008. JAMA 2010, 303(20):2043-2050. 10.1001/jama.2010.650, 20501926.
4. Wilkins K, Campbell RC, Joffres MR, McAlister FA, Nichol M, Quach S, Johanssen HC, Tremblay MS. Blood pressure in Canadian adults. Statistics Canada, Catalogue no. 82-003-XPE. Health Reports 2010, 21(1).
5. Yawn BP, Casey M, Hebert P. The Rural Health Care Workforce Implications of Practice Guideline Implementation. Med Care 1999, 27:259-269.
6. Supina AL, Guirguis LM, Majumdar SR, Lewanczuk RZ, Lee TK, Toth EL, Johnson JA. Treatment gaps for hypertension management in rural Canadian patients with Type 2 diabetes. Clin Ther 2004, 26:596-606.
7. Thompson A, Campbell NR, Cloutier L, Costello JA, Dawes M, Hickey J, Kaczorowski J, Lewanczuk RZ, Semchuk W, Tsuyuki RT. Tackling the burden of hypertension in Canada: Encouraging collaborative care. Can Fam Physician 2008, 54:1659-1662. 2602620, 19074693.
8. Chabot I, Moisan J, Grégoire JP, Milot A. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003, 37(9):1186-1193. 10.1345/aph.1C267, 12921497.
9. Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME Study). J Gen Intern Med 2005, 20(12):1091-1096. 10.1111/j.1525-1497.2005.0226.x, 1490290, 16423096.
10. Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, Chrischilles EA, Franciscus CL, Xu Y. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009, 169:1996-2002. 10.1001/archinternmed.2009.358, 2882170, 19933962.
11. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension. Arch Intern Med 2009, 169:1748-1755. 10.1001/archinternmed.2009.316, 2882164, 19858431.
12. McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT. A Randomized Trial of the Effect of Community Pharmacist and Nurse Care on Improving Blood Pressure Management in Patients With Diabetes Mellitus. Arch Intern Med 2008, 168(21):2355-2361. 10.1001/archinte.168.21.2355, 19029501.
13. Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: Review of international developments. J Pharm Pharm Sci 2005, 8:217-225.
14. Government of Alberta Health Professions Act. 2006, Chapter H-7, Section 16 (3) and (4);, Government of Alberta.
15. Cooper RJ, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, James V, Lymn J, McIntosh A, Murphy E, Ratcliffe J, Read S, Ward P. Nurse and pharmacist supplementary prescribing in the UK - a thematic review of the literature. Health Policy 2008, 85:277-292. 10.1016/j.healthpol.2007.07.016, 17900744.
16. Lloyd F, Hughes CM. Pharmacists' and mentors' views on the introduction of pharmacist supplementary prescribing: a qualitative evaluation of views and context. Int J Pharm Prac 2007, 15:31-37.
17. Tully MP, Latif S, Cantrill JA, Parker D. Pharmacists' changing views of their supplementary prescribing authority. Pharm World Sci 2007, 29:628-34. 10.1007/s11096-007-9114-2, 17380422.
18. Canadian Hypertension Education Program 2010 CHEP Recommendations for the Management of Hypertension. Canadian Hypertension Education Program., http://hypertension.ca/chep/wpcontent/uploads/2010/04/FullRecommendations2010.pdf
19. Chan AHW, Campbell NR, Lewanczuk RZ, Semchuk W, Thompson A, Tsuyuki RT. 2008 Canadian Hypertension Education Program Guidelines for the management of hypertension by pharmacists. Can Pharm J 2008, 141:327-331.
20. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002, 39:S1-S266. National Kidney Foundation.
21. Chan P, Grindrod K, Bougher D, Pasutto F, Wilgosh C, Eberhart G, Tsuyuki RT. A systematic review of remuneration systems for clinical pharmacy care services. CPJ 2008, 141(2):102-112.
22. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension awareness, prevalence, treatment and control rates in US adults between 1988 - 1994 and 1999 - 2004. Hypertension 2008, 52:818-827. 10.1161/HYPERTENSIONAHA.108.113357, 18852389.
23. Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older Americans about high blood pressure: implications for health care policy, education and research. Arch Intern Med 2003, 163:681-687. 10.1001/archinte.163.6.681, 12639200.
24. Zhang X, Zhu M, Dib HH, Hu J, Tang S, Zhong T, Ming X. Knowledge, awareness, behavior (KAB) and control of hypertension among urban elderly in Western China. Int J Cardiol 2008,
25. Oliveria SA, Chen RS, McCarthy BD, Davis CC, Hill MN. Hypertension knowledge, awareness and attitudes in a hypertensive population. J Gen Intern Med 2005, 20:219-225. 10.1111/j.1525-1497.2005.30353.x, 1490067, 15836524.
26. Ragot S, Sosner P, Bouche G, Guillemain J, Herpin D. Appraisal of the knowledge of hypertensive patients and assessment of the role of pharmacists in the management of hypertension: results of a regional survey. J Hum Hypertens 2005, 19:577-584. 10.1038/sj.jhh.1001859, 15830000.
27. Keshishian F, Colodny N, Boone RT. Physician-patient and pharmacist-patient communication: geriatrics' perceptions and opinions. Patient Educ Couns 2008, 71:265-284. 10.1016/j.pec.2008.01.004, 18308499.
28. Bungard TJ, Koshman SL, Tsuyuki RT. Patient preferences for ongoing warfarin management after receiving care by an anticoagulation management service. Am J Health-Syst Pharm 2008, 65:1498-1500. 10.2146/ajhp070274, 18693199.
29. Tonna AP, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK - a literature review of current practice and research. J Clin Pharm Ther 2007, 32:545-556. 10.1111/j.1365-2710.2007.00867.x, 18021331.
30. Guillame L, Cooper R, Avery A, Mitchell S, Ward P, Anderson C, Bissell P, Hutchinson A, James V, Lymn J, McIntosh A, Murphy E, Ratcliffe J. Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006. J Clin Pharm Ther 2008, 33:11-6. 10.1111/j.1365-2710.2008.00869.x, 18211611.